IE891773L - Process for preparing optically active 2-(aryloxy)- or¹2-(arylthio)alkanoic acids - Google Patents
Process for preparing optically active 2-(aryloxy)- or¹2-(arylthio)alkanoic acidsInfo
- Publication number
- IE891773L IE891773L IE891773A IE177389A IE891773L IE 891773 L IE891773 L IE 891773L IE 891773 A IE891773 A IE 891773A IE 177389 A IE177389 A IE 177389A IE 891773 L IE891773 L IE 891773L
- Authority
- IE
- Ireland
- Prior art keywords
- aryloxy
- arylthio
- acid
- microorganism
- racemic
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract 3
- 239000002253 acid Substances 0.000 claims abstract description 23
- 150000001408 amides Chemical class 0.000 claims abstract description 13
- 244000005700 microbiome Species 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 5
- 230000007062 hydrolysis Effects 0.000 claims abstract description 4
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 10
- 241000186146 Brevibacterium Species 0.000 claims description 8
- AQIHDXGKQHFBNW-UHFFFAOYSA-N 2-(4-hydroxyphenoxy)propanoic acid Chemical compound OC(=O)C(C)OC1=CC=C(O)C=C1 AQIHDXGKQHFBNW-UHFFFAOYSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000003301 hydrolyzing effect Effects 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- 150000002825 nitriles Chemical class 0.000 claims description 3
- 108010033272 Nitrilase Proteins 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 claims 1
- 125000005110 aryl thio group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 150000007513 acids Chemical class 0.000 abstract description 4
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 abstract description 4
- DOZZSWAOPDYVLH-UHFFFAOYSA-N 2-phenylpropanamide Chemical compound NC(=O)C(C)C1=CC=CC=C1 DOZZSWAOPDYVLH-UHFFFAOYSA-N 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- OKEABHYXUHCZON-UHFFFAOYSA-N 2-(4-hydroxyphenoxy)propanamide Chemical compound NC(=O)C(C)OC1=CC=C(O)C=C1 OKEABHYXUHCZON-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 238000001212 derivatisation Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 241000186216 Corynebacterium Species 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 239000002028 Biomass Substances 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Chemical compound OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- AQIHDXGKQHFBNW-ZCFIWIBFSA-N (2r)-2-(4-hydroxyphenoxy)propanoic acid Chemical compound OC(=O)[C@@H](C)OC1=CC=C(O)C=C1 AQIHDXGKQHFBNW-ZCFIWIBFSA-N 0.000 description 1
- SXERGJJQSKIUIC-UHFFFAOYSA-N 2-Phenoxypropionic acid Chemical compound OC(=O)C(C)OC1=CC=CC=C1 SXERGJJQSKIUIC-UHFFFAOYSA-N 0.000 description 1
- NVAOLENBKNECGF-UHFFFAOYSA-N 2-phenylpropanenitrile Chemical compound N#CC(C)C1=CC=CC=C1 NVAOLENBKNECGF-UHFFFAOYSA-N 0.000 description 1
- SMVCUJHUXYLBIQ-UHFFFAOYSA-N 2-phenylsulfanylpropanoic acid Chemical compound OC(=O)C(C)SC1=CC=CC=C1 SMVCUJHUXYLBIQ-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000010364 biochemical engineering Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- WOFDVDFSGLBFAC-UHFFFAOYSA-N lactonitrile Chemical compound CC(O)C#N WOFDVDFSGLBFAC-UHFFFAOYSA-N 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Process for preparing optically active 2-aryloxy- or 2-arylthioalkanoic acids by enantioselective hydrolysis of the corresponding racemic amides in the presence of a microorganism or of an enzyme selected as a function of its ability to selectively hydrolyse racemic alpha -phenylpropionamide to S alpha -phenylpropionic acid.
Description
f. X 9 G ^ -J e~ y The present invention relates to the preparation of optically active 2-(aryloxy)- or 2-(arylthio)alkanoic acids of general formula: in which Ar denotes an aromatic radical, optionally substituted by at least one alkyl, alkoxy, halo or hydroxyl group, the alkyl or alkoxy groups preferably having 1 to 4 carbon atoms each; A denotes an oxygen or sulphur atom; R denotes an alkyl radical having 1 to 6 carbon atoms.
More especially, the present invention provides a process for the preparation of an R-(+) enantiomer of a 2-(aryloxy)- or 2-(arylthio)alkanoic acid of general formula (I), and more particularly an R-(+) enantiomer of a 2-phenoxy- or 2-(phenylthio)propionic acid of general formula: J* CO 2 H (II) Ar in which Ar has the same meaning as in formula I and, most preferably, (R)-(+)-2-(4-hydroxyphenoxy)propionic acid. i According to the present invention, the 2-(aryloxy)-or 2-(arylthio)alkanoic acids of formula (I) in the R form * are obtained by the enantioselective hydrolysis of the corresponding racemic amides optionally prepared in situ in the presence of a microorganism which is a Brevibacterium or Corvnebacterium strain, or an enzyme derived from a said microorganism, having nitrilase activity and able to 10 hydrolyse racemic a-phenylpropionamide enantioselectively to (S)- a-phenylpropionic acid with an enantiomeric excess of more than 65%, and then separating the (R)-2-(aryloxy)-or -2-(arylthio)alkanoic acid from the unhydrolysed amide of the (S)-2-(aryloxy)- or -2-(arylthio)alkanoic acid. 15 The selection of the agent which brings about the enantioselective hydrolysis of the racemic amide of the 2-(aryloxy)- or (2-(arylthio)alkanoic acid of general formula (I) is accomplished by bringing the agent into contact with racemic a-phenylpropionamide in a suitable medium until 20% 20 of the product is converted, and then measuring the enantiomeric excess.
The microorganisms which are especially suitable are chosen from Brevibacterium R312 (CBS 717.73) and Corvnebacterium N711 (FERM P 4445) or Corvnebacterium N774 ^ (FERM P 4446), which enable (S)-2-arylalkanoic acids to be obtained with an enantiomeric excess of S isomer generally of more than 90% from the corresponding amide.
It is surprising to note that, among these microorganisms, Brevibacterium R312, which is described in French Patent Specification FR 7,901,803/2,447,359 and in Advances in Biochemical Engineering, vol. 14, p. 1-32 (1980) 5 as possessing non-stereospecific general amidase, hydrolyses the racemic amides of 2-arylalkanoic acids stereospecifically, whereas its A4 mutant, which possesses a stereospecific L-amidase, does not hydrolyse the racemic amides of 2-arylalkanoic acids.
It is appropriate to note that Corynebacterium N771 and Corynebacterium N774, which are described in European Patent Specification EP 0,187,680, hydrolyse, for example, lactonitrile to DL-lactic acid and a-aminophenyl-propionitrile to DL-phenylalanine without stereoselectivity 15 being observed.
The process of the present invention is generally carried out in an aqueous or homogeneous or heterogeneous aqueous-organic medium, under temperature and pH conditions determined in accordance with the nature of the microorganisms or the enzyme used, by stirring a suspension of cells or cell extracts of the microorganism and the amide of the racemic 2-(aryloxy)- or 2-(arylthio)alkanoic acid.
The process leads to a mixture of the (R)-2- (aryloxy)- or -2-(arylthio)alkanoic acid and the amide of the (S)-2-(aryloxy)- or -2-(arylthio)alkanoic acid. At the end of the process the (R)-form acid and the (S)-form amide are separated.
When the microorganism used possesses the property of hydrolysing nitriles, combined with the property of enantioselectively hydrolysing a-phenylpropionamide, it is possible to obtain an (R)-2-phenoxy- or -2-(phenylthio)alkanoic acid either from the nitrile of the 15 racemic 2-phenoxy- or 2-(phenylthio)alkanoic acid or from the amide of the racemic 2-phenoxy- or 2-(-phenylthio) alkanoic acid.
The examples which follow show how the invention may be put into practice.
EXAMPLE 1 a) Brevibacterium strain R 312 (CBS 717.73) is cultured in an agitated flask at 28°C for 14 hours in a medium whose composition is as follows: Glucose 10 g (NH4)2S04 5 g KH2P04 1.01 g Na2HP04 .12H20 1.64 g K2HP04 0.82 g CaCl2.2HZ0 0.012 g ZnCl2 0.0012 g FeS0A.7H20 0.0012 g MnS04.H20 0 . 00 12 g MgS0A.7H20 0.5 g Thiamine hydrochloride 0.002 g Water g.s. 1000 cm3 This preculture is used for inoculating a culture medium having the same composition but containing N-10 methylacetamide at a concentration of 20 mM. Culturing is performed in an agitated flask for 24 hours at 28°C. The biomass obtained is separated by centrifugation and then washed twice with sodium chloride solution at a concentration of 9 g/litre. 15 b) A centrifugation pellet containing 13 mg of Brevibacterium R 312 cells, expressed as dry matter, is suspended in 2 cm3 of phosphate buffer (50 mM) at pH 7.25 mg of racemic 2-phenylpropionitrile (190 /jmol) are added. After 24 hours' agitation at 25°C, the reaction 20 mixture is diluted by adding 23cm3 of an acetonitrile/N-hydrochloric acid (90:10 by volume) mixture. The bacteria are removed by centrifugation. The composition of the supernatant is determined by high performance liquid chromatography (HPLC).
The supernatant contains: 119 /jmol of 2-phenylpropionamide 62 /tmol of 2-phenylpropionic acid.
Sodium chloride is added to promote separation of the aqueous and organic phases. After evaporation of the organic phase to dryness, the residue is taken up with 20 cm3 of a chloroform/0.1 N sodium hydroxide (1:1 by 5 volume) mixture.
The basic phase is acidified and extracted with chloroform.
Measurement of the optical rotation shows that the enantiomeric excess of S-(+) isomer is 100%. 10 After derivatization of r.he 2-phenylpropionic acid with (R)-(+)-a-methylbenzylamine, analysis by HPLC shows that the enantiomeric excess is 96.4%.
EXAMPLE 2 A centrifugation pellet containing 1.33 mg of 15 Brevibacterium R 312 cells, expressed as dry matter, is suspended in 2 ml of phosphate buffer (50 mM) at pH 7.0. 32.6 mg of racemic 2-(4-hydroxyphenoxy)propion-amide (0.180 mmol) are added. After 24 hours' agitation at 25°C, the reaction mixture is diluted by adding 23 cm3 20 of an acetonitrile/N hydrochloric acid (90:10 by volume) mixture. The bacteria are removed by centrifugation. The composition of the supernatant is determined by high performance liquid chromatography (HPLC): 0.0884 mmol of 2-(4-hydroxyphenoxy)propionamide 25 0.0864 mmol of 2-(4-hydroxyphenoxy)propionic acid.
Sodium chloride is added to promote separation of the organic and aqueous phases. After evaporation of the organic phase to dryness, the residue is taken up with 10 ml of ethyl acetate plus 6 ml of a 10% w/v solution of 5 sodium hydrogen carbonate in water. After settling has taken place, the aqueous solution is separated and extracted with twice 10 ml of ethyl acetate. The aqueous phase is acidified to pH 1.0 with N hydrochloric acid solution and then extracted with three times with 10 ml 10 ethyl acetate. These organic phases containing the acid are dried over sodium sulphate and evaporated to dryness. The residue is taken up in acetone. Measurement of the optical rotation of this acetone solution shows that the enantiomeric excess of R-(+) isomer is 99%. 15 After derivatization of the 2-(4-hydroxyphenoxy)- propionic acid with (R)-(+)-a-methylbenzylamine, HPLC analysis shows that the enantiomeric excess of R-(+) isomer is 94%.
EXAMPLE 3 a) Corvnebacterium strain N 771 (FERM P 4445) is cultured in an agitated flask at 28°C for 14 hours in a medium having the following composition: yeast extract 3 g malt extract 3 g lactopeptone 5 g glucose 10 g FeSO*. 7H20 0.1 g water g.s. 1 litre and the pH of which is adjusted to 7.5 by adding sodium hydroxide before sterilization.
This preculture is used for inoculating, at a 1:40 ratio, a medium of the same composition.
After incubation for 24 hours at 28°C in an agitated flask, the biomass is separated by centrifugation and then washed twice with aqueous sodium chloride solution at a concentration of 9 g/litre. b) A centrifugation pellet containing 11.3 mg of Corvnebacterium N 771 cells, expressed as dry matter, is suspended in 2 cm3 of phosphate buffer (50 mM) pH 7. 34 mg of racemic 2-(4-hydroxyphenoxy)propionamide (0.187 mmol) are added, and the mixture is then stirred for 24 hours at 25°C. The reaction mixture is treated under the conditions of Example 2.
The supernatant contains: 0.083 mmol of 2-(4-hydroxyphenoxy)propionamide 0.079 mmol of 2-(4-hydroxyphenoxy)propionic acid.
The enantiomeric excesses of 2-(4-hydroxyphe-noxy)propionic acid, measured by the optical rotation and after derivatization with (R)-(+)-a-methylbenzylamine, are, respectively, 95% and 91% in respect of the R-( + ) isomer.
EXAMPLE 4 Corynebacterium N774 cells are prepared under the conditions described in Example 3a) for the preparation of a cell pellet of Corvnebacterium N771.
A centrifugation pellet containing 10.8 mg of Corvnebacterium N774 cells, expressed as dry matter, is suspended in 2 cm3 of phosphate buffer (50 mM) pH 7. 34.5 mg of racemic 2-(4-hydroxyphenoxy)propion-amide (0.190 mmol) are added and the mixture is then stirred for 24 hours at 25°C. The reaction mixture is treated under the conditions of Example 1.
The supernatant contains: 0.078 mmol of 2-(4-hydroxyphenoxy)propionamide 0.080 mmol of 2-(4-hydroxyphenoxy)propionic acid.
The enantiomeric excesses of 2-(4-hydroxyphenoxy) propionic acid, measured by the optical rotation and after derivatization with (R)-(+)-a-methylbenzylamine, are, respectively, 95% and 92% in respect of the R-( + ) isomer.
Claims (7)
1. Process for preparing an R-( + ) enantiomer of a 2-(aryloxy)- or 2-(arylthio)alkanoic acid of formula: A CCOH (I) 10 in which Ar denotes an optionally substituted aromatic radical, R denotes an alkyl radical having 1 to 6 carbon atoms and A denotes an oxygen or sulphur atom, which comprises enantioselectively hydrolysing an amide of the corresponding racemic 2-(aryloxy) - or 2-(arylthio)alkanoic 15 acid, optionally prepared in situ, in the presence of a microorganism which is a Brevibacterium or Corvnebacterium strain, or an enzyme derived from a said microorganism, having nitrilase activity and able to hydrolyse racemic a-phenylpropionamide enantioselectively to (S) - cx-20 phenylpropionic acid with an enantiomeric excess of more than 65%, and then separating the (R)-2-(aryloxy)- or -2-(arylthio)alkanoic acid from the unhydrolysed amide of the (S)-2-(aryloxy)- or -2-(arylthio)alkanoic acid.
2. Process according to claim 1, in which the said 25 microorganism is Brevibacterium R 312 (CBS 717.73), Corvnebacterium N 771 (FERM P 444 5) or Corvnebacterium N 774 (FERM P 4446). - 12 -
3. Process according to claim 1, in which the starting amide is obtained in situ by hydrolysis of the nitrile of the racemic 2-(aryloxy)- or 2-(arylthio)alkanoic acid in the presence of the microorganism used or of the enzyme derived from this microorganism.
4. Process according to any one of claims 1 to 3 in which the acid produced has the formula: Ar 0^ ^ C0,H (II) in which Ar has the same meaning as in claim 1.
5. Process according to claim 4, in which the compound of formula (II) is 2-(4-hydroxyphenoxy)propionic acid in the R-(+) form.
6. Process according to claim 1 substantially as described in any one of Examples 1 to 4.
7. An enantiomer of a 2-(aryloxy)- or 2- (arylthio)alkanoic acid as defined in claim 1 when produced by the process claimed in any of claims 1 to 6. F.R. Kelly & Co., Agents for the Applicants.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8807009A FR2631975B1 (en) | 1988-05-26 | 1988-05-26 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALKANOIC ARYLOXY-2 OR ARYLTHIO-2 ACIDS |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE891773L true IE891773L (en) | 1989-11-26 |
| IE63329B1 IE63329B1 (en) | 1995-04-19 |
Family
ID=9366642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE177389A IE63329B1 (en) | 1988-05-26 | 1989-06-12 | Process for preparing optically active 2-(aryloxy) - or 2-(arylthio) alkanoic acids |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0344044B1 (en) |
| JP (1) | JPH0279996A (en) |
| AT (1) | ATE107364T1 (en) |
| DE (1) | DE68916111T2 (en) |
| ES (1) | ES2055122T3 (en) |
| FR (1) | FR2631975B1 (en) |
| IE (1) | IE63329B1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK314989A (en) * | 1988-06-27 | 1989-12-28 | Asahi Chemical Ind | PROCEDURE FOR THE PREPARATION OF OPTICALLY ACTIVE ALFA-SUBSTITUTED ORGANIC ACIDS, AND MICRO-ORGANISMS AND ENZYMES USED IN THE PROCEDURE |
| US5258305A (en) * | 1991-09-13 | 1993-11-02 | Nitto Chemical Industry Co., Ltd. | Manufacture of optically active 2-phenylpropionic acid and 2-phenylpropionamide from the nitrile using Rhodococcus equi |
| DE60120216T2 (en) * | 2000-12-11 | 2007-03-29 | Mitsubishi Gas Chemical Co., Inc. | Process for the preparation of optically active (4R) -1,3-thiazolidine-4-carboxylic acid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1342844A (en) * | 1961-09-16 | 1963-11-15 | Bayer Ag | Process for the preparation of substituted, optically active phenoxyacetic acids |
| DK261685A (en) * | 1985-06-11 | 1986-12-12 | Novo Industri As | PROCEDURE FOR MANUFACTURING OPTIC ACTIVE ORGANIC COMPOUNDS |
| DE3532026A1 (en) * | 1985-09-09 | 1987-03-19 | Hoechst Ag | METHOD FOR PRODUCING OPTICALLY ACTIVE (ALPHA) -PHENOXYPROPIONIC ACID AND ITS DERIVATIVES |
-
1988
- 1988-05-26 FR FR8807009A patent/FR2631975B1/en not_active Expired - Lifetime
-
1989
- 1989-05-12 DE DE68916111T patent/DE68916111T2/en not_active Expired - Lifetime
- 1989-05-12 EP EP89401339A patent/EP0344044B1/en not_active Expired - Lifetime
- 1989-05-12 AT AT89401339T patent/ATE107364T1/en not_active IP Right Cessation
- 1989-05-12 ES ES89401339T patent/ES2055122T3/en not_active Expired - Lifetime
- 1989-05-22 JP JP1126821A patent/JPH0279996A/en active Granted
- 1989-06-12 IE IE177389A patent/IE63329B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2631975A1 (en) | 1989-12-01 |
| JPH0279996A (en) | 1990-03-20 |
| EP0344044B1 (en) | 1994-06-15 |
| IE63329B1 (en) | 1995-04-19 |
| EP0344044A1 (en) | 1989-11-29 |
| JPH0569518B2 (en) | 1993-10-01 |
| DE68916111D1 (en) | 1994-07-21 |
| DE68916111T2 (en) | 1994-09-22 |
| FR2631975B1 (en) | 1990-11-30 |
| ES2055122T3 (en) | 1994-08-16 |
| ATE107364T1 (en) | 1994-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU616933B2 (en) | Process for the preparation of optically active 2-arylpropionic acids | |
| EP0348901A2 (en) | Process for producing optically active alfa-substituted organic acid and microorganism and enzyme used therefor | |
| US5034329A (en) | Process for the preparation of optically active 2-arylalkanoic acids | |
| EP0264457A1 (en) | Process for preparing optically active cyclopropanecarboxylic acids | |
| EP0330695B1 (en) | Process for preparation of organic chemicals | |
| RU2144959C1 (en) | Enzymatic hydrolysis of 4-methylthiobutyronitriles | |
| IE912338A1 (en) | Process for producing enantiomers of 2-aryl-alkanoic acids | |
| JP3694065B2 (en) | Biotechnological process for producing cyclic S-α-aminocarboxylic acid and R-α-aminocarboxamide | |
| EP0549710B1 (en) | A process for the preparation of enantiomeric 2-alkanoic acids | |
| IE891773L (en) | Process for preparing optically active 2-(aryloxy)- or¹2-(arylthio)alkanoic acids | |
| US5593871A (en) | Process for the preparation of enantiometric 2-alkanoic acid amides from nitriles | |
| JP2670838B2 (en) | Method for producing L-α-amino acids | |
| KR20070026439A (en) | Culture Method of Nitrile Hydrolase-producing Strain Rhodococcus Rhodocrose M33 | |
| CA2035877A1 (en) | Preparation of d-malic acid or derivative | |
| JPS62118899A (en) | Production of l-carnitine | |
| EP0352846A1 (en) | Process for the preparation of biocatalysts with previously absent stereoselective enzyme activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed |